Sex differences in the cardiovascular consequences of diabetes mellitus: a scientific statement from the American Heart Association
JG Regensteiner, S Golden, AG Huebschmann… - Circulation, 2015 - Am Heart Assoc
For years, it has been recognized that the incidence of coronary heart disease (CHD) in
women lags behind that of men by≈ 10 years, 7 thus generating hypotheses that …
women lags behind that of men by≈ 10 years, 7 thus generating hypotheses that …
HDL-targeted therapies: progress, failures and future
BA Kingwell, MJ Chapman, A Kontush… - Nature reviews Drug …, 2014 - nature.com
Since the discovery in the 1970s that plasma levels of high-density lipoprotein cholesterol
(HDL-C) are inversely associated with cardiovascular outcome, it has been postulated that …
(HDL-C) are inversely associated with cardiovascular outcome, it has been postulated that …
[HTML][HTML] Rationale and design of ApoA-I Event Reducing in Ischemic Syndromes II (AEGIS-II): A phase 3, multicenter, double-blind, randomized, placebo-controlled …
CM Gibson, JJP Kastelein, AT Phillips, PE Aylward… - American heart …, 2021 - Elsevier
Acute myocardial infarction (MI) patients remain at high risk for recurrent events. Cholesterol
efflux, mediated by apolipoprotein AI, removes excess cholesterol from atherosclerotic …
efflux, mediated by apolipoprotein AI, removes excess cholesterol from atherosclerotic …
Lecithin: cholesterol acyltransferase–from biochemistry to role in cardiovascular disease
X Rousset, B Vaisman, M Amar, AA Sethi… - Current opinion in …, 2009 - journals.lww.com
Lecithin: cholesterol acyltransferase – from biochemistry to... : Current Opinion in
Endocrinology, Diabetes and Obesity Lecithin: cholesterol acyltransferase – from …
Endocrinology, Diabetes and Obesity Lecithin: cholesterol acyltransferase – from …
Nanodiscs: Game changer nano-therapeutics and structural biology tools
In recent years, engineering biocompatible HDL nanodiscs has garnered a great interest
with wide applications for for both drug delivery and structural biology. In this review, we …
with wide applications for for both drug delivery and structural biology. In this review, we …
HDL in sepsis–risk factor and therapeutic approach
EE Morin, L Guo, A Schwendeman, XA Li - Frontiers in pharmacology, 2015 - frontiersin.org
High-density lipoprotein (HDL) is a key component of circulating blood and plays essential
roles in regulation of vascular endothelial function and immunity. Clinical data demonstrate …
roles in regulation of vascular endothelial function and immunity. Clinical data demonstrate …
Fast and accurate estimation of selection coefficients and allele histories from ancient and modern DNA
We here present CLUES2, a full-likelihood method to infer natural selection from sequence
data that is an extension of the method CLUES. We make several substantial improvements …
data that is an extension of the method CLUES. We make several substantial improvements …
CSL112 enhances biomarkers of reverse cholesterol transport after single and multiple infusions in healthy subjects
A Gille, R Easton, D D'Andrea, SD Wright… - … , and vascular biology, 2014 - Am Heart Assoc
Objective—The ability of apolipoprotein AI (apoA-I) to transport cholesterol from
atherosclerotic plaque is thought to underlie its inverse correlation with cardiovascular risk …
atherosclerotic plaque is thought to underlie its inverse correlation with cardiovascular risk …
The effect of phospholipid composition of reconstituted HDL on its cholesterol efflux and anti-inflammatory properties [S]
A Schwendeman, DO Sviridov, W Yuan, Y Guo… - Journal of lipid …, 2015 - ASBMB
The goal of this study was to understand how the reconstituted HDL (rHDL) phospholipid
(PL) composition affects its cholesterol efflux and anti-inflammatory properties. An ApoA-I …
(PL) composition affects its cholesterol efflux and anti-inflammatory properties. An ApoA-I …
Apolipoprotein mimetic peptides: potential new therapies for cardiovascular diseases
Since the seminal breakthrough of treating diabetic patients with insulin in the 1920s, there
has been great interest in developing other proteins and their peptide mimetics as therapies …
has been great interest in developing other proteins and their peptide mimetics as therapies …